Prognostic effect of surgery of metastases in patients with advanced gastric cancer: Real-world data from the AGAMENON registry
Paula Jiménez‐Fonseca(Hospital Universitario Central de Asturias), Pilar Felices(Hospital Universitario Miguel Servet), Alfonso Martín Carnicero(Hospital San Pedro), M. Ferrer(Deleted Institution), E. Buxó Orra(Hospital de Sant Pau), María Luisa Limón(Sorbonne Université), Carlos López(Ministerio de Salud Pública), Laura Visa(Hospital Del Mar), Rodrigo Sánchez-Bayona(Research Institute Hospital 12 de Octubre), José Barreto(Hospital Universitario de Canarias), Ana Custodio(Hospital Universitario La Paz), Ismael Macías(Hospital de Galdakao), A. Viúdez(Universidad Pública de Navarra (UPNA)), Manuel Sánchez Cánovas(Pontificia Universidad Católica de Chile), A. Ramchandani Vaswani(Hospital Universitario Insular de Gran Canaria), Paula Cerdá(Hospital Quirón Teknon), I. Echavarria Diaz-Guardamino(Hospital General Universitario Gregorio Marañón), Raquel Hernández(Hospital Municipal de Badalona)
Cited by 0
Related Papers
Nivolumab plus Ipilimumab in Microsatellite-Instability–High Metastatic Colorectal Cancer
|New England Journal of Medicine|2024|208
Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer Registry
|British Journal of Cancer|2017|106
Support systems to guide clinical decision-making in precision oncology: The Cancer Core Europe Molecular Tumor Board Portal
|Nature Medicine|2020|89
Neoadjuvant Immune Checkpoint Inhibitors Plus Chemotherapy in Early Breast Cancer
|JAMA Oncology|2024|77